Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

BeiGene (BGNE) announced its intent to change the company’s name to “BeOne Medicines Ltd.,” confirming its commitment ... driven by strong growth in product revenue in the U.S. and Europe. To support ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

"Physicians have limited time and don't need repetitive information. The transfer must be efficient, with scientifically ...

I thought and realized that I really have something to tell people, and it’s also more about talking openly about that part ...

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax ...

Americans are stockpiling reproductive health medications amid fears of restrictions under the next administration.